Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-089133
Filing Date
2010-04-22
Accepted
2010-04-21 19:08:21
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO.1 d10ka.htm 10-K/A 59695
2 SUBLICENSE AGREEMENT, BY AND BETWEEN SANGAMO AND JOHNSON & JOHNSON dex103.htm EX-10.3 103983
3 PATENT LICENSE AGREEMENT BETWEEN SANGAMO AND MIT dex104.htm EX-10.4 75043
4 LICENSE AGREEMENT BETWEEN SANGAMO AND THE JOHNS HOPKINS UNIVERSITY dex105.htm EX-10.5 95603
5 RULE 13A-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 3923
6 RULE 13A-14(A) CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 3699
  Complete submission text file 0001193125-10-089133.txt   343419
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30171 | Film No.: 10762729
SIC: 2836 Biological Products, (No Diagnostic Substances)